Loading
IARC estimates 9,539 new cancer cases and 5,461 cancer deaths in El Salvador in 2024; the commonest new cancers are prostate, breast and stomach. This page is assembled automatically from OnCo's data: 1 trial with a site there, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Prostate | 1,506 | 47.3 | Prostate cancer |
| Breast | 1,061 | 26.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Stomach | 826 | 11.2 | Gastric & gastro-oesophageal junction cancer |
| Cervix uteri | 779 | 18.9 | Cervical cancer |
| Colorectum | 545 | 7.4 | Colorectal cancer |
| Liver and intrahepatic bile ducts | 446 | 6.1 | Hepatocellular carcinoma |
| Leukaemia | 413 | 5.9 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Trachea, bronchus and lung | 412 | 5.5 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Brain, central nervous system | 267 | 3.9 | Glioma & glioblastoma |
| Thyroid | 225 | 3.0 | Thyroid cancer |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Stomach | 670 | 9.0 | Gastric & gastro-oesophageal junction cancer |
| Cervix uteri | 462 | 11.2 | Cervical cancer |
| Liver and intrahepatic bile ducts | 418 | 5.7 | Hepatocellular carcinoma |
| Trachea, bronchus and lung | 375 | 5.0 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Prostate | 347 | 11.4 | Prostate cancer |
| Colorectum | 316 | 4.3 | Colorectal cancer |
| Breast | 290 | 7.2 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Leukaemia | 283 | 4.0 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Brain, central nervous system | 219 | 3.2 | Glioma & glioblastoma |
| Pancreas | 208 | 2.8 | Pancreatic ductal adenocarcinoma |
| Trial | Lead sponsor | ||||
|---|---|---|---|---|---|
APHINITY NCT01358877 | Phase 3 | Completed | Hoffmann-La Roche | 546 | 2025-11-28 |
Trial records in OnCo whose ClinicalTrials.gov entry lists at least one site in El Salvador, captured 2026-10-07 to 2026-10-07. Recruiting first, then the most recently updated. The status is the study's overall status; whether a site in El Salvador is open is on the registry page, under Contacts and Locations.
OnCo holds no institution, company or person in El Salvador.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. El Salvador is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
El Salvador is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.